Henry Schein Inc. closed $13.54 short of its 52-week high ($82.63), which the company achieved on February 27th.

Henry Schein Inc. closed $14.08 below its 52-week high ($82.63), which the company achieved on February 27th.

Henry Schein has strategically set up distribution centers worldwide to better serve customers and increase its operating ...

Valued at a market cap of $8.8 billion, Henry Schein, Inc. (HSIC) provides healthcare products and services to dental ...

Henry Schein is a candidate surfaced by a screen in this sector. It has many characteristics that I like in companies: easy-to-understand business, and profitable, among many others. There are ...

Henry Schein, Inc.’s HSIC joint venture, Henry Schein One, is driving strong growth in its core products and introducing new solutions. The company’s robust acquisition strategy helps it to ...

Henry Schein is a leading global distributor of health-care products and services primarily to office-based dental and medical practitioners. The company operates through two segments that offer ...

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and ...

Henry Schein’s presentations can be heard via live webcast by visiting www.henryschein.com/IRwebcasts. Replays will be available on the Henry Schein website ...

As of December 3, 2024, the average one-year price target for Henry Schein is $75.79/share. The forecasts range from a low of $55.55 to a high of $87.15. The average price target represents an ...

The leading distributor of healthcare products and services has a market capitalization of $9.12 billion. Henry Schein surpassed estimates in three of the trailing four quarters and missed the same in ...